Filing Details

Accession Number:
0001562180-24-007036
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-10-01 16:17:06
Reporting Period:
2024-09-30
Accepted Time:
2024-10-01 16:17:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1822791 Clene Inc. CLNN Pharmaceutical Preparations (2834) 852828339
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1835330 Dee Robert Etherington 6550 South Millrock Drive
Suite G50
Salt Lake City UT 84121
Chief Executive Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-09-30 10,000 $4.75 40,149 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrants (Right to buy) Acquisiton 2024-09-30 10,000 $0.13 10,000 $4.82
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
10,000 2024-10-01 2029-10-01 No 4 A Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 636 Indirect By LLC
Common Stock 1,250 Indirect By trust
Footnotes
  1. The securities are owned by RDE RX Ventures LLC. Mr. Etherington is the manager of RDE RX Ventures LLC. The shares owned by RDE RX Ventures LLC may also be deemed to be beneficially owned by Mr. Etherington.
  2. The securities are owned by the Etherington Revocable Trust. Mr. Etherington is the co-trustee of the Etherington Revocable Trust. The shares owned by the Etherington Revocable Trust may be deemed to be beneficially owned by Mr. Etherington.